LBT Innovations Limited (AU:LBT) has released an update.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
LBT Innovations Limited, an Australian leader in microbiology automation, showcased its advanced Automated Plate Assessment System (APAS® Independence) at the 2024 AGM. This AI-powered technology, which is the only US FDA-cleared solution for automated culture plate assessment, is being distributed by Thermo Fisher Scientific to clinical labs in the US and Europe. The system is revolutionizing microbiology labs by automating the analysis of culture plates, enhancing efficiency in the pharmaceutical and clinical sectors.
For further insights into AU:LBT stock, check out TipRanks’ Stock Analysis page.